Clinical Forecasting using Ex Vivo Drug Sensitivity Profiling of Acute Myeloid Leukemia
Aram Nikolai Andersen, Andrea M. Brodersen, Pilar Ayuda Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Lizet Baken, Julia Fredriksen, Mia Stoksflod, Andrea Lenartova, Yngvar Fløisand, Jorrit M. Enserink
This study evaluates ex vivo drug sensitivity profiling in AML patients to predict survival and chemotherapy response, showing its robustness in mapping treatment response signatures.
bioRxiv · Oct 11, 2022 · PreprintBioinformatics